Salute e Benessere

Novo Nordisk A/S: Notice for the Annual General Meeting of Novo Nordisk A/S

Bagsværd, Denmark, 27 February 2025 – The Annual General Meeting of Novo Nordisk A/S will be held on: Thursday 27 March 2024 at 14.00 (CET) The Annual General Meeting is held as a partially electronic general meeting. Accordingly, shareholders can choose between participating in person at Bella Center, Center Boulevard 5, DK-2300 Copenhagen S, Denmark or participating virtually via an IT application. We encourage shareholders to exercise their rights by submitting proxies or votes by...
Nasdaq GlobeNewswire
27/02/2025

Philips expands cloud-based enterprise imaging services to Europe for better…

Accelerating cloud adoption across Europe with Philips HealthSuite Imaging cloud services on Amazon Web Services Amsterdam, The Netherlands –Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, announced today the expansion of its cloud-based radiology informatics solutions to Europe, including exploring the use of generative AI to enhance radiology reporting. After the successful migration of over 150 sites in North and Latin America to HealthSuite Imaging on...
Nasdaq GlobeNewswire
27/02/2025

Metabolon Unveils New Multiomics Biomarker Discovery Functionality via its…

The global multiomics market was valued at $2.4 billion in 2023 and is projected to reach $6.4 billion by 2030. Since 2012, scientific publications featuring multiomic data have increased 63% annually. Despite the growing importance of multiomics research, successfully combining genomic, transcriptomic, proteomic, and metabolomic data can be time-consuming and expensive. Metabolon's new multiomics biomarker discovery functionality provides powerful and easily accessible online bioinformatics…
PR Newswire
27/02/2025

Tiziana Life Sciences Announces Groundbreaking Study Published in Nature…

Traumatic brain injury is a leading cause of death and disabilityCurrently, there is no treatment to prevent the long-term effects of traumatic brain injuryFindings could translate into treating intracerebral hemorrhage or stroke NEW YORK, Feb.27, 2025(GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq:TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab,...
Nasdaq GlobeNewswire
27/02/2025

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in…

The $2 million in new funding is part of a $4 million commitment from Teva, launched in 2022, to expand access to critical mental health services across 10 states “Every day uninsured patients face barriers to accessing basic mental health services they need,” said Carol Richardson, Sustainability and Health Equity Lead, Teva U.S. “This latest round of grant funding will enable clinics in more states to expand existing or develop innovative new behavioral health programs that meet the needs...
Nasdaq GlobeNewswire
27/02/2025

uniQure Announces 2024 Financial Results and Highlights Recent Company Progress

~ Announced alignment with the U.S. Food and Drug Administration (FDA) on key elements of the Accelerated Approval pathway for AMT-130 in Huntington's disease; Initiated preparations for a potential Biologics License Application (BLA) submission ~~ Completed patient enrollment in the third cohort of the Phase I/II study of AMT-130 ~~ Initiated dosing of the Phase I/II study of AMT-260 in mesial temporal lobe epilepsy (mTLE);Implementing protocol changes to expand study inclusion...
Nasdaq GlobeNewswire
27/02/2025

KFNCCC Welcomes Georgina Rodríguez's Visit to Support Young Cancer Patients

Rodríguez distributed specially designed "Baby Pelones" dolls to children battling cancer RIYADH, Saudi Arabia, Feb.27, 2025(GLOBE NEWSWIRE) -- The King Fahad National Centre for Children's Cancer (KFNCCC), a subsidiary of the King Faisal Specialist Hospital and Research Centre (KFSHRC), in collaboration with the Spanish charity Juegaterapia Foundation, welcomed Georgina Rodríguez for a special visit aimed at bringing joy to young cancer patients.Rodríguez, accompanied by Mónica...
Nasdaq GlobeNewswire
27/02/2025

United Imaging Intelligence Highlights Sustainable AI Solutions at ECR 2025

Adhering to the "Born with AI" philosophy, AI has been embedded across United Imaging's full equipment portfolio. This includes CT, MRI, PET/CT, PET/MR, XR, RT, and Mammography. The AI-powered innovations enhance the speed, safety, and efficiency of imaging systems, contributing to more intelligent healthcare delivery. Adhering to the "Born with AI" philosophy, AI has been embedded across United Imaging's full equipment portfolio. This includes CT, MRI, PET/CT, PET/MR, XR…
PR Newswire
27/02/2025

Orion Corporation: Managers' transactions – Satu Ahomäki

ORION CORPORATIONMANAGERS' TRANSACTIONS27 FEBRUARY 2025 at 11.00 EET Orion Corporation: Managers' transactions – Satu Ahomäki Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification...
Nasdaq GlobeNewswire
27/02/2025

Orion Corporation: Managers' transactions – Hao Pan

ORION CORPORATIONMANAGERS' TRANSACTIONS27 FEBRUARY 2025 at 11.00 EET Orion Corporation: Managers' transactions – Hao Pan Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Corporation - Managers' Transactions ____________________________________________ Person subject to the...
Nasdaq GlobeNewswire
27/02/2025

Trading by management and close relations of management

The Executive Leadership Team members eligible for the Novozymes A/S 2022-2024 incentive program has on February 26, 2025, received the allocated shares. An overview of the number and value of shares allotted is provided on the attached file. Attachment 2025_04_Trading_By_Management
Nasdaq GlobeNewswire
27/02/2025

Brainomix Partners with Medtronic to Enhance Stroke Care Across Western Europe

By combining Brainomix's AI-powered imaging technology with Medtronic's expertise in neurovascular treatments, the partnership represents a significant step forward in stroke care. The collaboration will support faster, more accurate diagnoses, enabling healthcare professionals across the region to make better-informed decisions and deliver life-saving interventions more efficiently By combining Brainomix's AI-powered imaging technology with Medtronic's expertise in neurovascular treatments,...
PR Newswire
27/02/2025

Clarivate Report Explores Opportunities for Innovation and Market Expansion in…

Latin America's pharmaceutical market, valued at $98 billion, is projected to grow by 10.1% between 2021 and 20251. Discussions at the 2023 Summit LATAM in Barcelona and the 2024 Summit LATAM at CPhI Milan underscored the need for collaboration among industry stakeholders, government agencies, and academia to strengthen regional innovation and competitiveness. With increasing global demand for pharmaceuticals, Latin America has the potential to become a key player in the industry by leveraging…
PR Newswire
27/02/2025

Invitation to presentation of Sectra's nine-month interim report 2024/2025

To participate, follow the instructions on Sectra's website investor.sectra.com/q3report2425. The broadcast will be made available on the same webpage after the conference. To participate, follow the instructions on Sectra's websiteinvestor.sectra.com/q3report2425. The broadcast will be made available on the same webpage after the conference. Participation will take place via Microsoft Teams. Questions can be posed using the chat function or by sending questions in advance via email to...
PR Newswire
27/02/2025

US FDA grants Priority Review to Sobi's supplemental Biologics Licence…

"HLH/MAS in Still's disease is a serious and potentially fatal complication where patients can experience intense hyperinflammation and even multiple organ failure," said Lydia Abad-Franch, MD, MBA, Head of R&D and Chief Medical Officer at Sobi. "There is no approved therapy for HLH/MAS today. Gamifant® (emapalumab-Izsg) selectively neutralizes interferon gamma (IFN-γ), a key driver of hyperinflammation, and if approved, may also help reduce the need for high-dose…
PR Newswire
27/02/2025

RAMSAY SANTE :Ramsay Health Care Limited Financial advisor announcement - 27…

PRESS RELEASE Paris, February 27 th2025 Ramsay Health Care Limited announces that it has appointed a financial advisor to review its strategic options associated with its majority shareholding in Ramsay Générale de Santé Ramsay Générale de Santé has taken note of the press release issued today by its Australian reference shareholder Ramsay Health Care Limited announcing that it has appointed a financial advisor to further explore and advise on strategic options associated with its...
Nasdaq GlobeNewswire
27/02/2025

Significant milestone reached for EG 427 with first patient treated with EG110A…

First patient now successfully dosed in the EG110A clinical study being conducted at four leading US institutionsPhase 1b/2a study to recruit 16 patients with neurogenic detrusor overactivity (neurogenic bladder) -related incontinence following spinal cord injuryFirst application worldwide of non-replicative herpes-based vectors in neuro-urologyOpens possibility of bringing genetic medicine to large disease populations in neurologyParis, France, February 27, 2025– EG 427, a...
Nasdaq GlobeNewswire
27/02/2025

Pharming Group to report fourth quarter and full year 2024 financial results on…

Leiden, the Netherlands, February 27, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) fourth quarter and full year 2024 financial results, for the period ended December 31, on Thursday, March 13, 2025. Pharming will host a presentation for analysts and investors at 13:30 CET/08:30 am EDT on March 13, 2025. To participate in the conference call, please register in advance using the link below. Once...
Nasdaq GlobeNewswire
27/02/2025

Invitation to the presentation of Systemair's third quarter report 2024/25

Press and analyst meeting will be organised at 09:00 CET on March 6, 2025. The report will be presented by Roland Kasper, CEO, and Anders Ulff, CFO. Press and analyst meeting will be organised at09:00 CETonMarch 6, 2025. The report will be presented byRoland Kasper, CEO, and Anders Ulff, CFO. To participate in the webcast: If you would like to participate in the webcast, please register via the link below. There will be an opportunity to ask questions at any time during the...
PR Newswire
27/02/2025

Hydrofast Launches Innovative Countertop Water Filters, Revolutionizing Healthy…

Hydrofast specializes in compact, eco-friendly home appliances, including countertop and under-sink water purifiers, coffee machines, and kitchen waste disposers. The 2025 roadmap includes seven new eco-friendly home products, with water purification as the flagship category. Hydrofast specializes in compact, eco-friendly home appliances, including countertop and under-sink water purifiers, coffee machines, and kitchen waste disposers. The 2025 roadmap includes seven new eco-friendly home...
PR Newswire
27/02/2025

PCI Biotech full year 2024 interim results

Highlights review OperationsPCI Biotech's 2024 development goals were to demonstrate scalability and manufacturing process benefits of the photochemical-based technology (PCL) in viral vector (AAV) manufacturing by advancing the technology into mini benchtop bioreactors, which are considered representative for commercial manufacturing. Recent mini benchtop bioreactor results indicate that PCL has the potential to release increased levels of viral vectors in the upstream AAV...
Nasdaq GlobeNewswire
27/02/2025

IBA Notice of Full Year 2024 Results and Conference Call

FY24 results meeting to take place as a hybrid event on Thursday, 20 March 2025 at 2:30pm CET Louvain-la-Neuve, Belgium, 27 February 2025- IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today that it will publish its consolidated results for the full year 2024 onThursday, 20 March 2025 at 7am CET.Conference Call Information IBA's management team will host a hybrid event, including a conference call and webcast...
Nasdaq GlobeNewswire
27/02/2025

The debate on MSCs is over; it's time to promote MSC therapy in practice

Using advanced single-cell RNA sequencing (scRNA-seq) and pseudotime trajectory analysis, the research group identified that stem cells exhibit robust self-renewal and differentiation capabilities, mesenchymal stromal cells (MSCs) lack the expression of these critical stemness genes. These genes include SOX2, NANOG, POU5F1, SFRP2, DPPA4, SALL4, ZFP42 and MYCN. On the other hand, there are five critical stromal cell functional genes, TMEM119, FBLN5, KCNK2, CLDN11 andDKK1, that are only expressed…
PR Newswire
27/02/2025

Genesis MedTech Successfully Completes First Robotic-Assisted Surgery

OMNIBOT is transforming surgical precision across multiple specialties, including urology, gynaecology, thoracic, and general surgery. Compared to traditional techniques, robotic-assisted surgery offers better visualization, greater dexterity, and improved ergonomics for surgeons. Patients benefit from smaller incisions, reduced blood loss, fewer complications, and faster recovery. OMNIBOT is transforming surgical precision across multiple specialties, including urology, gynaecology…
PR Newswire
27/02/2025
Altri  Comunicati